AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02150564 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Navigation
Description: Routine microneurosurgical procedures would be adopted in all cases.Sonowand system will be used for navigation control arm as well as sononavigation experimental arm. Image registration (on the previously imported DICOM images) will be done on the system and after positioning, patient-toimage registration will be completed. The Registration accuracy will be documented.
Study NCT02871128 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Natureheme-iron
Description: An 12 week double-blinded randomized parallel study with 4 week follow-up period was performed in mild anemia subjects. Consenting eligible subjects were receive 2 capsules per day containing either 1000 mg Fe of similar appearance for 12 weeks. The subjects were required to visit at baseline, every 6 weeks during the intervention period (6 weeks), and at follow-up 4 weeks after treatment had ended. During each study visit, fasting blood samples were collected and anthropometric measurements were performed. Compliance was evaluated using a food diary and monitored with biweekly telephone calls.
Study NCT02871128 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: An 12 week double-blinded randomized parallel study with 4 week follow-up period was performed in mild anemia subjects. Consenting eligible subjects were receive 2 capsules per day containing either 1000 mg starch placebo of similar appearance for 12 weeks. The subjects were required to visit at baseline, every 6 weeks during the intervention period (6 weeks), and at follow-up 4 weeks after treatment had ended. During each study visit, fasting blood samples were collected and anthropometric measurements were performed. Compliance was evaluated using a food diary and monitored with biweekly telephone calls.
Study NCT02871128 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: supplement
Description: An 12 week double-blinded randomized parallel study with 4 week follow-up period was performed in mild anemia subjects. Consenting eligible subjects were receive 1 capsule per day containing either 100 mg Fe of similar appearance for 12 weeks. The subjects were required to visit at baseline, every 6 weeks during the intervention period (6 weeks), and at follow-up 4 weeks after treatment had ended. During each study visit, fasting blood samples were collected and anthropometric measurements were performed. Compliance was evaluated using a food diary and monitored with biweekly telephone calls.
Study NCT00322010 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: early PT OT
Description: 1. Passive range of motion exercises for all limbs in patients who remain unresponsive despite sedative interruption (ten repetitions in all cardinal directions).~2. Sessions began with active assisted and active range of motion exercises in the supine position.~3. If tolerated, treatment is advanced to bed mobility activities, including transferring to upright sitting.~4. Sitting balance activities are followed by participation in activities of daily living (ADLs) and exercises that encourage increased independence with functional tasks.~5. The session progresses to transfer training, and finally pre-gait exercises and ambulation.~6. Progression of activities is dependent on patient tolerance and stability.~7. Therapy intervention continues on a daily basis throughout the patient's hospital stay until he/she returns to prior level of function or is discharged.
Study NCT01331616 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab (Avastin)
Description: Dosage is: 10 mg/kg every 2 weeks as monotherapy or in combination (unlabeled) with irinotecan. Patients will also receive Radiotherapy prior to beginning chemotherapy.
Study NCT03323528 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Benzalkonium Chloride-Benzocaine Topical
Description: Dorithricin = tyrothricin, benzalkonium chloride, benzocaine
Study NCT03323528 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: Placebo Oral Tablet = a lozenge with matched appearance and the same excipients as Active Comparator Dorithricin lozenge.~Intervention: Patients are instructed to administer at home 1 lozenge at intervals of 2 hours (±15 minutes) up to a maximum of 8 lozenges per day.
Study NCT02259933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KUC 7483 CL
Study NCT02259933 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03907683 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Short Message with Text and Optional Image
Description: Messages can be up to 256 characters of text and with or without an image. Move more and sit less messages were written to target established cognitive and affective constructs associated with physical activity (e.g., prompts to action plan, guidance for maximizing pleasure by regulating intensity).
Study NCT02579746 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: DASHNa-CC
Description: The 8-week DASHNa-CC intervention incorporated Dietary Approach to Stop Hypertension (DASH) diet, sodium reduction with the food therapy of Traditional Chinese Medicine, and included an intervention manual, two sessions of classroom instruction delivered in Mandarin, and a 20-minute telephone follow-up.
Study NCT02579746 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: usual care
Description: education booklet, encouragement of physician visit, use of public health resources if needed
Study NCT02579746 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: usual care
Description: education booklet, encouragement of physician visit, use of public health resources if needed
Study NCT02310178 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Bariatric surgery
Description: all of the current bariatric surgeries are allowed in this prospective cohort study
Study NCT04770376 — intervention group
Intervention type: OTHER
Intervention: Observational study. Blood samples will be collected at scheduled blood draws performed as per clinical practice before each cycle of chemotherapy.
Description: Collection of blood samples during blood draws performed before each cycle of chemotherapy as per clinical practice.
Study NCT00983554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anastrazole
Description: Arimidex 1mg daily
Study NCT00983554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone
Description: Testim 10g daily
Study NCT00983554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dutasteride
Description: Avodart 2.5mg daily
Study NCT00983554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GnRH antagonist
Description: Acyline 300 µg/kg subcutaneous injections every 2 weeks
Study NCT01248663 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: antecolic reconstruction
Description: see study arm description
Study NCT01248663 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: retrocolic reconstruction
Description: see study arm description
Study NCT01803945 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AVE8112
Study NCT01803945 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03778606 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Potato starch
Description: Potato starch will be given twice a day for up to 14 days, discharge, or death, whichever occurs first.
Study NCT03339609 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Uroflow
Description: Isolated uroflow measurement
Study NCT03339609 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Uroflow/EMG
Description: Uroflow measurement with superficial EMG testing of the pelvic floor
Study NCT02948686 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Self-Etching Application Strategy
Description: In Group SET, the adhesive system Ambar Universal will be used in 55 teeth, according to the manufacturer's instructions, in the self-etching mode. The adhesive system will be brushed during 10 seconds in the cavity, will be air-dried during 5 seconds, brushed again during 10 seconds, air-dried during 10 seconds and activated during 10 seconds with LED light; After applying the adhesive, the restorations will be made with composite resin Opallis (FGM, Joinville, Brazil), and evaluated every 6 months for pain assessment, shape, staining or recurrent caries, using scores.
Study NCT02948686 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enamel Etching Application Strategy
Description: In Group SEE, 37% phosphoric acid will be applied during 15 seconds, only in enamel in 55 teeth. This acid will be removed using water, the cavity will be air-dried, and then, the adhesive system Ambar Universal will be brushed during 10 seconds in the cavity, will be air-dried during 5 seconds, brushed again during 10 seconds, air-dried during 10 seconds and activated during 10 seconds with LED light; After applying the adhesive, the restorations will be made with composite resin Opallis (FGM, Joinville, Brazil), and evaluated every 6 months for pain assessment, shape, staining or recurrent caries, using scores.
Study NCT02948686 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self Etching with Extended time Application Strategy
Description: In Group SETT, the adhesive system Ambar Universal will be used in 55 teeth, in the self-etching mode. The adhesive system will be brushed during 20 seconds in the cavity, will be air-dried during 5 seconds, brushed again during 20 seconds, air-dried during 10 seconds and activated during 10 seconds with LED light; After applying the adhesive, the restorations will be made with composite resin Opallis (FGM, Joinville, Brazil), and evaluated every 6 months for pain assessment, shape, staining or recurrent caries, using scores
Study NCT02948686 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self Etching with Extended layers number Strategy
Description: In Group SETL, the adhesive system Ambar Universal will be used in 55 teeth, in the self-etching mode. The adhesive system will be brushed during 10 seconds in the cavity, will be air-dried during 5 seconds, brushed again during 10 seconds, air-dried during 5 seconds, brushed again during 10 seconds, air-dried during 5 seconds, brushed again during 10 seconds, air-dried during 5 seconds, and activated during 10 seconds with LED light; After applying the adhesive, the restorations will be made with composite resin Opallis (FGM, Joinville, Brazil), and evaluated every 6 months for pain assessment, shape, staining or recurrent caries, using scores
Study NCT02332421 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: modified dentoalveolar distractor
Description: Here, the modified distractor is going to be used when retracting the canine.
Study NCT04064840 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IVF: Decapeptyl and hCG
Description: When at least three follicles reach 18 mm in diameter, recombinant hCG 0.25mg and decapeptyl 0.2mg will be injected subcutaneously.
Study NCT04064840 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FET: Decapeptyl
Description: On the day of FET, decapeptyl 0.1 mg will be injected subcutaneously.
Study NCT04064840 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: IVF: hCG and normal saline
Description: When at least three follicles reach 18 mm in diameter, recombinant hCG 0.25mg and normal saline will be injected subcutaneously.
Study NCT04064840 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: FET: Normal Saline
Description: On the day of FET, normal saline will be injected subcutaneously.
Study NCT03416023 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TIES® (Transcutaneous Implant Evacuation System)
Description: Transcutaneous Implant Evacuation System
Study NCT03401827 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy (Gemcitabine + nab-paclitaxel)
Description: Nanoparticle albumin-bound paclitaxel (125 mg/m2) miv over 30 min, Day 1,8,15~Gemcitabine (1,000mg/m2) and N/S 150mL miv over 30 min, Day 1,8,15
Study NCT01758991 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcranial direct current stimulation (tDCS)
Description: tDCS is a safe and painless transcranial stimulation that modulates brain activity and could improve stroke recovery. Electrodes in soaked sponges are placed over specific brain regions and held with an elastic band. Direct current is then applied through the electrodes. The patients may feel nothing or a slight tingling under the electrodes.
Study NCT01758991 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: transcranial direct current stimulation (tDCS)
Description: tDCS is a safe and painless transcranial stimulation that modulates brain activity and could improve stroke recovery. Electrodes in soaked sponges are placed over specific brain regions and held with an elastic band. Direct current is then applied through the electrodes. The patients may feel nothing or a slight tingling under the electrodes.
Study NCT04044404 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound Integrated Precision Diagnosis Technology(ultrasound elastography)
Description: Compare the ultrasound Integrated Precision Diagnosis Technology(ultrasound elastography) with the diagnostic gold standard of kidney disease---kidney biopsy
Study NCT01875900 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Video-assisted learning and self-directed training
Description: The Neonatal Resuscitation Program (NRP) DVD will be provided for video study and a low-fidelity newborn manikin for self-directed resuscitation training (90 minutes training time, six students per group).
Study NCT01875900 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simulation-based neonatal resuscitation training
Description: Students will learn initial assessment of newborns and basic resuscitation skills and actively apply these skills during simulated clinical scenarios both with a low- and high-fidelity manikin (90 minutes training time, six students per group).
Study NCT00889928 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NOTES GEN 1 Toolbox
Description: * Articulating Hook Knife~* Articulating Snare~* Articulating Needle Knife~* Articulating Graspers~* Articulating Biopsy Forceps~* Steerable Flex Trocar with Rotary Access Needle~* Flexible Bipolar Hemostasis Forceps~* Flexible Maryland Dissector
Study NCT02288949 — intervention group
Intervention type: OTHER
Intervention: stratification
Description: Patients will be stratified based on the values of relevant demographics, pulmonary and systemic variables in relation to mortality in the intensive care unit.
Study NCT03792880 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telematic control and self-management program
Description: During 6 months with CPAP treatment, patients must complete some questionnaires about the presence of refreshing sleep and side effects with the frequency established, using a computing application. Patients can download this application on their own smartphone but, if they prefer, they can be provided with a tablet during the study with this application installed.~A set of variables will be collected using an automatic and wireless transmission from latest generation CPAP to control the CPAP compliance and tolerance. All data will be processed in a platform to generate alarms, which will be controled daily by a researcher, as well as solutions to the problems presented during the monitoring.
Study NCT03792880 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Habitual follow-up in Healthcare System
Description: According to the SEPAR regulation, patients treated with CPAP should be evaluated by the pulmonologist one month after beginning treatment, every 3 months during the first year, every 6 months during the second year and annually from the third year.
Study NCT03792880 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Habitual follow-up in Healthcare System
Description: According to the SEPAR regulation, patients treated with CPAP should be evaluated by the pulmonologist one month after beginning treatment, every 3 months during the first year, every 6 months during the second year and annually from the third year.
Study NCT00732732 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Green banana powder
Description: Green banana in powder form, 10 grams/ day for children below 10 kg, 20 grams for those weighing 10 Kg or more. Protocol Modified on Aug 5th 2009 to give 20 grams irrespective of age.
Study NCT00732732 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Microcrystalline cellulose
Description: Microcrystalline cellulose 10 gm/ day for subjects below 10 kg in weight, 20 gms/ day for those weighing 10 Kg or more
Study NCT03426995 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered as a matching oral solution or matching capsule to study drug GSK3358699, during Part A and C once daily
Study NCT03426995 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK3358699
Description: GSK3358699, will be administered from 1 mg to 45 mg as an oral solution (1 to 10 mg) or as a capsule (3 to 45 mg), in Part A, B and Part C once daily.
Study NCT01996098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 6-month Icotinib
Description: 125 mg three times daily (375 mg per day) by mouth for 6 months
Study NCT01996098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 12-month icotinib
Description: 125 mg three times daily (375 mg per day) by mouth for 12 months
Study NCT01738295 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Donepezil administration
Study NCT01738295 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo administration
Study NCT01202175 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nebivolol
Description: Oral nebivolol 2.5-5mg once daily
Study NCT01202175 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nebivolol
Description: Oral nebivolol 2.5-5mg once daily
Study NCT03888469 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Verofilcon A contact lenses
Description: Investigational daily disposable soft contact lenses
Study NCT03888469 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Etafilcon A contact lenses
Description: Commercially available daily disposable soft contact lenses
Study NCT02828293 — intervention group
Intervention type: OTHER
Intervention: Dynamic videofluoroscopic analysis
Description: Patients bearing 3 different prosthesis (3 groups) will be prospactively assessed with videofluoroscopy.
Study NCT03426995 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GM-CSF
Description: The GM-CSF will be administered as an intravenous infusion to subjects as 60 microgram per meter\^2 in Part A (Day 1) and Part C (Day 14).This will be administered for 2 hours approximately, no later than 24 hours post -dose of the GSK3358699 or placebo in Part C
Study NCT03339609 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: US
Description: Ultrasound of post void residual urine
Study NCT03426995 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: GM-CSF
Description: The GM-CSF will be administered as an intravenous infusion to subjects as 60 microgram per meter\^2 in Part A (Day 1) and Part C (Day 14).This will be administered for 2 hours approximately, no later than 24 hours post -dose of the GSK3358699 or placebo in Part C
Study NCT01487967 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Preference and Goal Instrument
Description: Families in the intervention arm will receive culturally appropriate educational material, complete the Preference and Goal Instrument at the study start, use the results to inform decision making about ADHD treatment, have their preferences/goals tracked in the electronic health record, and have their progress toward their goals assessed at 3 months and 6 months (approximately).
Study NCT02632045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LEE-011
Description: 600 mg capsule (3x 200 mg capsules)
Study NCT02632045 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Fulvestrant
Description: 500 mg injection
Study NCT03499067 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Test lens
Description: Contact lens
Study NCT03499067 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test lens
Description: Contact lens
Study NCT03499067 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control lens
Description: Contact lens
Study NCT01417403 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hydroxychloroquine
Description: Given PO
Study NCT01417403 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy
Description: Undergo radiotherapy
Study NCT03499067 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Control lens
Description: Contact lens
Study NCT04658966 — intervention group
Intervention type: OTHER
Intervention: administration of a self-questionnaire
Description: Women will have to fill in an online self questionnaire on pre-eclampsia
Study NCT02892045 — intervention group
Intervention type: DEVICE
Intervention: MMG
Description: neuromuscular monitoring device
Study NCT00498147 — intervention group
Intervention type: OTHER
Intervention: ADEC Program
Description: Interventions (managed diabetes care) employed by the ADEC Program include: diabetes education, nutrition care, individual and group counseling sessions, foot care, and insulin and oral diabetes medication adjustments with a signed medical directive. ADEC Diabetes Educators (Registered Dietitians and Registered Nurses) will use adult education principles throughout the education process and promote self-care by encouraging responsibility and promoting a positive attitude towards acceptance of diabetes. All patients will be encouraged to self-monitor their blood glucose at home. Team member collaboration and with other agencies to promote a total client care approach to diabetes management will be employed.